Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (15), 1037-1040
- https://doi.org/10.1016/0002-9149(94)90279-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption systemThe American Journal of Cardiology, 1992
- Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1992
- Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemiaAtherosclerosis, 1991
- Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a “magic bullet”American Heart Journal, 1991
- Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty — A report from the M-HEART GrouptThe American Journal of Cardiology, 1990
- Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosisNature, 1989
- Restenosis after successful percutaneous transluminal coronary angioplasty: The montreal heart institute experienceThe American Journal of Cardiology, 1987
- Medical approaches to prevention of restenosis after coronary angioplastyJournal of the American College of Cardiology, 1987
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSISThe Lancet, 1978